Editorial contact at RxTA1

Editorial correspondence

RxTA1 concerns Thymosin Alpha-1 research. There is currently no public submission form or published editorial inbox on this site. This page therefore cannot receive a message.

The corrections I care about are concrete: the wrong study population, an outcome described too broadly, a source link that no longer reaches the paper, or a result attributed to the wrong peptide. A page path, the disputed sentence and the relevant paper title or DOI give enough detail to locate a problem.

There is no clinical consultation service attached to this page. Personal health records, treatment requests and dosing questions need an appropriate clinical channel.

Study details that change the answer

An omitted comparison treatment can make a combination sound like a test of TA1 alone. An observation made in mouse cells can be mistaken for a result in people. A survival association can acquire more certainty than its retrospective design allows. I regard each of those as a substantive error.

The complete references and the clinical research page identify the studies discussed here. They are available without submitting personal information.